Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Horizon Therapeutics Public Limited Company
Pharmaceutical Preparation ManufacturingIreland
Last verified 1 year agohorizontherapeutics.com
Horizon Therapeutics Public Limited Company, often referred to simply as Horizon Therapeutics, is a biopharmaceutical firm headquartered in Ireland (IE). Founded in 2008, the company has rapidly established itself within the global pharmaceutical industry, focusing on the development and commercialisation of innovative medicines for rare and rheumatic diseases.
Horizon Therapeutics is renowned for its core products, including Tepezza and Krystexxa, which address significant unmet medical needs. These therapies are distinguished by their unique mechanisms of action and commitment to improving patient outcomes. With a strong market position, Horizon has achieved notable milestones, including strategic acquisitions that have expanded its portfolio and global reach, particularly in North America and Europe.
45
DitchCarbon score
+3 vs industry average
Horizon Therapeutics Public Limited Company’s score of 45 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Horizon Therapeutics Public Limited Company?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Horizon Therapeutics Public Limited Company yet.
Horizon Therapeutics Public Limited Company's reported carbon emissions
Horizon Therapeutics Public Limited Company, headquartered in Ireland (IE), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Amgen Inc., and any emissions data or climate commitments may be inherited from this parent organisation.
As part of its climate initiatives, Horizon Therapeutics is aligned with the sustainability efforts of Amgen Inc., which has established various reduction targets and commitments. However, specific reduction targets or achievements for Horizon Therapeutics have not been disclosed.
The company is involved in broader industry climate initiatives, including those set forth by the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are linked to Amgen Inc. at the first cascade level. This indicates that Horizon Therapeutics is likely to follow the sustainability framework and targets established by its parent company.
In summary, while specific emissions data and reduction targets for Horizon Therapeutics are not available, the company is positioned within a corporate family that prioritises climate action and sustainability through its association with Amgen Inc.
Assessing Horizon Therapeutics Public Limited Company as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Horizon Therapeutics Public Limited Company and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Horizon Therapeutics Public Limited Company’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Horizon Therapeutics Public Limited Company yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Amgen Inc.2030 targetSee details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Horizon Therapeutics Public Limited Company yet.
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more